浆液性交界性卵巢肿瘤：磁共振成像特征的广泛综述。
Serous borderline ovarian tumours: an extensive review on MR imaging features.
机构信息
Department of Radiology, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK.
出版信息
Br J Radiol. 2021 Sep 1;94(1125):20210116. doi: 10.1259/bjr.20210116. Epub 2021 Jul 8.
Abstract
Serous borderline ovarian tumours (SBOTs) are an intermediate group of neoplasms, which have features between benign and malignant ovarian tumours and for which, fertility-sparing surgery can be offered. MRI in imaging of SBOTs is, therefore, crucial in raising the possibility of the diagnosis, in order to present the patient with the most appropriate treatment options. There are characteristic MRI features that SBOTs demonstrate. In addition, recent advanced techniques, and further classification into subtypes within the borderline group have been developed. The aim of this article is to review the MRI features of SBOT and provide the reporter with an awareness of the imaging tips and tricks in the differential diagnosis of SBOT.
摘要
浆液性交界性卵巢肿瘤（SBOT）是一种介于良性和恶性卵巢肿瘤之间的中间型肿瘤，可采用保留生育功能的手术治疗。因此，MRI 在 SBOT 的成像中具有重要作用，可以提高诊断的可能性，为患者提供最合适的治疗方案。SBOT 具有特征性的 MRI 特征。此外，最近还开发了一些先进的技术，并进一步将交界性肿瘤亚组进行分类。本文旨在回顾 SBOT 的 MRI 特征，并为报告者提供在 SBOT 鉴别诊断中影像学技巧的认识。
相似文献
1
Serous borderline ovarian tumours: an extensive review on MR imaging features.
Br J Radiol. 2021 Sep 1;94(1125):20210116. doi: 10.1259/bjr.20210116. Epub 2021 Jul 8.
2
Perfusion-based functional magnetic resonance imaging for differentiating serous borderline ovarian tumors from early serous ovarian cancers in a rat model.
Acta Radiol. 2021 Jan;62(1):129-138. doi: 10.1177/0284185120913711. Epub 2020 Apr 10.
3
MRI appearances of pure epithelial papillary serous borderline ovarian tumours.
Clin Radiol. 2015 Apr;70(4):424-32. doi: 10.1016/j.crad.2014.11.005. Epub 2014 Dec 13.
4
Role of MRI in characterizing serous borderline ovarian tumor and its subtypes: Correlation of MRI features with clinicopathological characteristics.
Eur J Radiol. 2022 Feb;147:110112. doi: 10.1016/j.ejrad.2021.110112. Epub 2021 Dec 21.
5
MRI appearances of borderline ovarian tumours.
Clin Radiol. 2009 Apr;64(4):430-8. doi: 10.1016/j.crad.2008.09.011. Epub 2008 Dec 20.
6
Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
BJOG. 2016 Mar;123(4):498-508. doi: 10.1111/1471-0528.13840. Epub 2015 Dec 25.
7
A rat model of serous borderline ovarian tumors induced by 7,12-dimethylbenz[a]anthracene.
Exp Anim. 2019 Aug 14;68(3):257-265. doi: 10.1538/expanim.18-0103. Epub 2019 Feb 14.
8
Ultrasound-Guided Laparoscopic Ovarian Wedge Resection in Recurrent Serous Borderline Ovarian Tumours.
Int J Gynecol Cancer. 2017 Nov;27(9):1813-1818. doi: 10.1097/IGC.0000000000001096.
9
[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging].
Gynecol Obstet Fertil Senol. 2020 Mar;48(3):260-276. doi: 10.1016/j.gofs.2020.01.014. Epub 2020 Jan 28.
10
MR imaging findings of low-grade serous carcinoma of the ovary: comparison with serous borderline tumor.
Jpn J Radiol. 2020 Aug;38(8):782-789. doi: 10.1007/s11604-020-00960-2. Epub 2020 Apr 3.
引用本文的文献
1
Case Report: Serous borderline ovarian tumor and extensive abdominopelvic endometriosis mimicking advanced epithelial ovarian cancer in a postmenopausal patient.
Front Med (Lausanne). 2025 Jun 17;12:1581241. doi: 10.3389/fmed.2025.1581241. eCollection 2025.
2
The Ultrasonography Characteristics of Borderline Ovarian Tumor Subtypes.
J Ultrasound Med. 2025 Jun 30. doi: 10.1002/jum.16756.
3
Habitat-based radiomics for preoperative differentiation between early-stage serous borderline ovarian tumors and malignant ovarian tumors.
Front Oncol. 2025 May 20;15:1559398. doi: 10.3389/fonc.2025.1559398. eCollection 2025.
4
O-RADS MRI scoring system: key points for correct application in inexperienced hands.
Insights Imaging. 2024 Apr 12;15(1):107. doi: 10.1186/s13244-024-01670-3.
5
Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors.
Abdom Radiol (NY). 2024 Jan;49(1):229-236. doi: 10.1007/s00261-023-04076-9. Epub 2023 Oct 20.
6
Computed Tomography Indicators for Differentiating Stage 1 Borderline Ovarian Tumors from Stage I Malignant Epithelial Ovarian Tumors.
Diagnostics (Basel). 2023 Jan 28;13(3):480. doi: 10.3390/diagnostics13030480.
7
Ovarian cancer during pregnancy.
Abdom Radiol (NY). 2023 May;48(5):1694-1708. doi: 10.1007/s00261-022-03768-y. Epub 2022 Dec 20.
8
female genitourinary oncology special feature: introductory editorial.
Br J Radiol. 2021 Sep 1;94(1125):20219003. doi: 10.1259/bjr.20219003.
本文引用的文献
1
Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors?
Abdom Radiol (NY). 2021 Jul;46(7):3354-3364. doi: 10.1007/s00261-021-03000-3. Epub 2021 Mar 3.
2
Multimodality Imaging Approach to Ovarian Neoplasms with Pathologic Correlation.
Radiographics. 2021 Jan-Feb;41(1):289-315. doi: 10.1148/rg.2021200086. Epub 2020 Nov 13.
3
MRI and FDG PET/CT Findings for Borderline Brenner Tumor of the Ovary: A Case Report and Literature Review.
Case Rep Obstet Gynecol. 2020 Aug 17;2020:8878649. doi: 10.1155/2020/8878649. eCollection 2020.
4
Borderline epithelial ovarian tumors: what the radiologist should know.
Abdom Radiol (NY). 2021 Jun;46(6):2350-2366. doi: 10.1007/s00261-020-02688-z. Epub 2020 Aug 29.
5
Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer.
Insights Imaging. 2020 Aug 17;11(1):94. doi: 10.1186/s13244-020-00895-2.
6
Radiomics derived from dynamic contrast-enhanced MRI pharmacokinetic protocol features: the value of precision diagnosis ovarian neoplasms.
Eur Radiol. 2021 Jan;31(1):368-378. doi: 10.1007/s00330-020-07112-0. Epub 2020 Aug 7.
7
Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for malignant ovarian tumors: a systematic review and meta-analysis.
Acta Radiol. 2021 Jul;62(7):966-978. doi: 10.1177/0284185120944916. Epub 2020 Aug 2.
8
Perfusion-based functional magnetic resonance imaging for differentiating serous borderline ovarian tumors from early serous ovarian cancers in a rat model.
Acta Radiol. 2021 Jan;62(1):129-138. doi: 10.1177/0284185120913711. Epub 2020 Apr 10.
9
MR imaging findings of low-grade serous carcinoma of the ovary: comparison with serous borderline tumor.
Jpn J Radiol. 2020 Aug;38(8):782-789. doi: 10.1007/s11604-020-00960-2. Epub 2020 Apr 3.
10
Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis.
Eur Radiol. 2020 Jun;30(6):3101-3112. doi: 10.1007/s00330-019-06524-x. Epub 2020 Feb 17.
Zotero 插件